Table 2.
Characteristics of the study cohort (n = 122)
| Variable | Data |
|---|---|
| Age, years, mean ± SD | 58.3 ± 6.8 |
| Waiting time, months, mean ± SD | 5.0 ± 3.5 |
| Pre-transplant AFP > 25 ng/ml, n (%) | 38a (38%) |
| Pre-transplant bridging therapy, n (%) | 88 (72%) |
| Pathology staging | |
| Within Milan Criteria | 68 (56%) |
| Exceeding Milan Criteria | 54 (44%) |
| Exceeding Milan, within expanded UCSF Criteria | 33 (27%) |
| Exceeding expanded UCSF Criteria | 21 (17%) |
| Max tumour size > 3 cm | 56b (48%) |
| Tumour count > 3 | 25 (20%) |
| Presence of vascular invasion | 19c (18%) |
| Bilobar | |
| On imaging and pathology | 45c (39%) |
| On pathology alone | 33d (31%) |
| Regional Review for Downstaging | 11 (9%) |
| Viable tumour on explant | 60e (73%) |
a–eData available for a101, b117, c106, d105 and e82 cases only.
SD, standard deviation; AFP, alpha-fetoprotein; UCSF, University of California San Francisco.